Cboe UK EUR

Moderna, Inc. (0QFD.XC)

22.90

-0.98

(-4.08%)

At close: May 30 at 2:42:24 PM GMT+1

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine ...

ACCESS Newswire yesterday

MRNA
Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates

LLY to acquire SiteOne for up to $1 billion. GSK's antibiotic study ends early for efficacy. MRNA loses H5 flu vaccine funding, while SNY sees mixed COPD data.

Zacks 2 days ago

MRNA

LLY

SNY
Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Biogen (NASDAQ:BIIB).

StockStory 2 days ago

BIIB

UTHR

VRTX
Trump admin. cancels Moderna bird fu vaccine contract

The Trump administration has canceled a contract with Moderna (MRNA) worth hundreds of millions of dollars. The contract was supposed to help Moderna develop a vaccine for humans to defend against bird flu. Yahoo Finance Senior Health Care Reporter Anjalee Khemlani reports the details in the video above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 2 days ago

MRNA
HHS cancels Moderna award, GE Vernova, Amazon-NY Times AI deal

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including the US Department of Health & Human Services (HHS) cancelling its $750 million reward for vaccine maker Moderna (MRNA), GE Vernova (GEV) shares approaching an all-time high, and Amazon (AMZN) striking an AI deal with the New York Times (NYT). Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. Editor's note: This video has been updated to correct the Amazon-New York Times story.

Yahoo Finance Video 3 days ago

NYT

AMZN

GEV
HHS cancels $766m bird flu vaccine contract with Moderna

The funding axe is just the latest hit to vaccine development by the HHS under RFK Jr.

Pharmaceutical Technology 3 days ago

MRNA
U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

The government scraps funding deal for MRNA's bird flu shot, despite encouraging safety and efficacy data from early clinical studies on the vaccine.

Zacks 3 days ago

MRNA

ADPT
Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash.

The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying sign for Moderna.

Barrons.com 3 days ago

MRNA
Moderna suffers a $750 million loss from NIH funding cut

Moderna's pipeline potential is being squeezed by the Trump administration.

Yahoo Finance 3 days ago

MRK

MRNA
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (NASDAQ:MRNA) announced today that its investigational H5 avian influenza vaccine, mRNA-1018, has shown promising interim results in a Phase 1/2 clinical trial involving 300 healthy adults. The vaccine, which uses Moderna, Inc. (NASDAQ:MRNA)’s mRNA technology, demonstrated a rapid, potent, and durable immune response. Three weeks after the second dose, nearly 98% of participants […]

Insider Monkey 3 days ago

MRNA
US cancels more than $700 million funding for Moderna bird flu vaccine

(Reuters) -The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced on Wednesday. Shares of Moderna were flat in after-market trading. This was in addition to $176 million awarded by the U.S. Department of Health and Human Services (HHS) last year to complete the late-stage development and testing of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza.

Reuters 3 days ago

MRNA
Moderna Announces Update on Investigational Pandemic Influenza Program

Phase 1/2 H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna's award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28, 2025 / Moderna, ...

ACCESS Newswire 3 days ago

MRNA
Moderna to Present at Upcoming Conferences in June 2025

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Jefferies Global Health Care Conference, on Thursday, June 5th at 10:30am ET Goldman Sachs ...

ACCESS Newswire 5 days ago

MRNA
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”

We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer thought of Moderna, Inc. (NASDAQ:MRNA), and he said: “There’s gotta be some value in […]

Insider Monkey 6 days ago

MRNA
MRNA Seeks FDA Nod for Updated COVID-19 Vaccine

Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.

Zacks 6 days ago

MRNA
COVID Vaccine Makers Catch a Break in FDA Policy Shift

Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales.

The Daily Upside 6 days ago

MRNA
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target variants from the JN.1 lineage, specifically favoring the LP.8.1 […]

Insider Monkey 8 days ago

MRNA
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

ACCESS Newswire 9 days ago

MRNA
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More

BMRN and NVAX are in the spotlight this week following announcement agreement and regulatory update.

Zacks 10 days ago

BMRN

PRME

INZY
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.

Zacks 10 days ago

MRNA

PFE

SNY

Performance Overview

Return	0QFD.XC	S&P 500 (^GSPC)
YTD	-40.28%	+0.51%
1-Year	-82.93%	+12.92%
3-Year	-83.18%	+42.17%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Moderna, Inc. (0QFD.XC)

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Trump admin. cancels Moderna bird fu vaccine contract

HHS cancels Moderna award, GE Vernova, Amazon-NY Times AI deal

HHS cancels $766m bird flu vaccine contract with Moderna

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash.

Moderna suffers a $750 million loss from NIH funding cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

US cancels more than $700 million funding for Moderna bird flu vaccine

Moderna Announces Update on Investigational Pandemic Influenza Program

Moderna to Present at Upcoming Conferences in June 2025

Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”

MRNA Seeks FDA Nod for Updated COVID-19 Vaccine

COVID Vaccine Makers Catch a Break in FDA Policy Shift

Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Performance Overview